Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 9.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000134 | Jake Dunning [Royaume-Uni] ; J. Kenneth Baillie [Royaume-Uni] ; BIN CAO [République populaire de Chine] ; Frederick G. Hayden [États-Unis] | Antiviral combinations for severe influenza |
| 000709 | Alan S. Perelson [Mexique] ; LIBIN RONG [Mexique, États-Unis] ; Frederick G. Hayden [États-Unis, Royaume-Uni] | Combination Antiviral Therapy for Influenza: Predictions From Modeling of Human Infections |
| 001778 | David Evans [Royaume-Uni] ; Simon Cauchemez [Royaume-Uni] ; Frederick G. Hayden [Royaume-Uni, États-Unis] | "Prepandemic" Immunization for Novel Influenza Viruses, "Swine Flu" Vaccine, Guillain-Barré Syndrome, and the Detection of Rare Severe Adverse Events |
| 001A24 | Adrian K. Ong [Suisse, Singapour] ; Frederick G. Hayden [Suisse, États-Unis] | John F. Enders lecture 2006 : Antivirals for influenza |
| 001B40 | Richard J. Whitley [États-Unis] ; John Bartlett [États-Unis] ; Frederick G. Hayden [États-Unis] ; Andrew T. Pavia [États-Unis] ; Michael Tapper [États-Unis] ; Arnold S. Monto [États-Unis] | Seasonal and pandemic influenza : Recommendations for preparedness in the united states |
| 001B51 | Beate Sander [Canada] ; Frederick G. Hayden [États-Unis] ; Marlene Gyldmark [Suisse] ; Louis P. Jr Garrison [Suisse] | Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK |
| 001C21 | Frederick G. Hayden [États-Unis] | Antiviral resistance in influenza viruses : Implications for management and pandemic response |
| 001C22 | Frederick G. Hayden [États-Unis] ; Andrew T. Pavia [États-Unis] | Antiviral management of seasonal and pandemic influenza |
| 001D29 | Frederick G. Hayden [États-Unis] | Pandemic influenza: Is an Antiviral response realistic? |
| This area was generated with Dilib version V0.6.34. |  |